With Covid-19 vaccines authorized for adults and teens, the FDA is now working to make sure the vaccines are safe and effective for younger children.
Here are the three main issues the FDA panel considered at its meeting today 🧵
politico.com/news/2021/06/1…
Here are the three main issues the FDA panel considered at its meeting today 🧵
politico.com/news/2021/06/1…
1. Safety:
The committee mainly focused on assessing whether the vaccines are safe for children.
One big consideration for regulators: Children's developing immune systems appear to react to Covid-19 differently than do those of adults.
politico.com/news/2021/06/1…
The committee mainly focused on assessing whether the vaccines are safe for children.
One big consideration for regulators: Children's developing immune systems appear to react to Covid-19 differently than do those of adults.
politico.com/news/2021/06/1…
2. Measuring efficacy:
Vaccine efficacy trials compare the number of infections in participants who got the shot to those who got a placebo.
But kids are less prone to symptomatic Covid, so a pediatric vaccine trial could take longer. politico.com/news/2021/06/1…
Vaccine efficacy trials compare the number of infections in participants who got the shot to those who got a placebo.
But kids are less prone to symptomatic Covid, so a pediatric vaccine trial could take longer. politico.com/news/2021/06/1…
3. How Covid vaccines mix with routine childhood shots:
People get most of their vaccinations during childhood. FDA asked its advisory panel for thoughts on whether kids should be able to get Covid vaccines alongside routine childhood immunizations. politico.com/news/2021/06/1…
People get most of their vaccinations during childhood. FDA asked its advisory panel for thoughts on whether kids should be able to get Covid vaccines alongside routine childhood immunizations. politico.com/news/2021/06/1…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
